Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the ...

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

Baird analyst Jeff Johnson lowered the firm’s price target on Tandem Diabetes (TNDM) to $37 from $39 and keeps a Neutral rating on the shares. The firm said Q3 revenue nicely exceeded the Street, ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Grew worldwide pump shipments by more than 25 percent ... "The third quarter marked a milestone achievement for Tandem Diabetes Care as we delivered the highest quarterly sales in our Company ...

Tandem Diabetes Care Inc (TNDM) achieves highest quarterly sales in history, driven by strong US and international growth, ...

On Friday, Tandem Diabetes Care Inc (TNDM) stock saw a decline, ending the day at $30.6 which represents a decrease of $-2.72 or -8.16% from the prior close of $33.32. The stock opened at $33.71 and ...

Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at ...